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Gender Bias in Skin Cancer: 
Role of Catalase Revealed
Deeba N. Syed1 and Hasan Mukhtar1
Sullivan et al. describe their finding that lower skin catalase activity in male as 
compared with female mice may be responsible for the increased skin carcino-
genesis observed in UVB radiation–exposed male mice. This adds to the growing 
literature that points toward a gender bias in the pathogenesis of skin cancer. 
Delineating the events between UV exposure and carcinogenesis in relation to 
skin’s antioxidant activity will provide insight into disease progression, progno-
sis, and responses to therapy. If substantiated with further studies in humans, 
this information may aid in designing gender-specific preventive measures 
aimed at reversing immune suppression through targeting the altered redox 
status in UV-exposed individuals.
Journal of Investigative Dermatology (2012) 132, 512–514. doi:10.1038/jid.2011.423
1Department of Dermatology, University of Wisconsin–Madison, Madison, Wisconsin, USA
Correspondence: Hasan Mukhtar, Department of Dermatology, University of Wisconsin–Madison, 
Medical Sciences Center, Room B25, 1300 University Avenue, Madison, Wisconsin 53706, USA. 
E-mail: hmukhtar@wisc.edu
Dermatologists have long witnessed 
more male than female patients with 
nonmelanoma skin cancer, which 
comprises approximately half of all 
diagnosed cancers in the United 
States. This assertion is supported by 
epidemiologic studies that report at 
least a twofold greater incidence of 
these cancers in men than in women 
(Schmitt et al., 2011). A combination 
of increased exposure and neglect 
was thought to play a dominant role in 
this discrepancy. Studies showed that 
on average men spend more hours in 
the sun and are less likely to employ 
sun protection techniques. Three times 
more men than women avoid doc-
tors when they have persistent, minor 
medical symptoms, and many neglect 
to obtain routine screenings for such 
conditions as cancers, even when 
sent reminders and offered free testing 
by their health plans (Schmitt et al., 
2011). However, the fact that this gen-
der difference was observed both in 
epidemiologic studies of humans and 
in animal studies suggests it may not 
be attributable entirely to sociological 
differences but also to specific biologi-
cal characteristics.
As our understanding of skin cancer 
increases, there is enhanced interest in 
delineating the role of gender differenc-
es in its pathogenesis. An earlier study 
demonstrated that male mice, upon 
exposure to UVB radiation, show more 
cutaneous oxidative DNA damage than 
do females and have lower antioxidant 
levels (Thomas-Ahner et al., 2007). In 
their recent study, Sullivan et al. (2012, 
this issue) showed that sex difference is 
an important predictor in responses to 
UVB-induced inflammation. UVB irradi-
ation inhibited skin catalase activity and 
increased myeloid cell skin infiltration. 
Interestingly, catalase supplementation 
in male mice significantly inhibited 
UVB-induced cellular infiltration of the 
skin.
Solar UV is considered a major etio-
logical factor in melanoma and non-
melanoma skin cancer. Reactive oxygen 
species (ROS) generated in response to 
UV irradiation participate in a number of 
pathophysiological processes, including 
DNA damage and lipid peroxidation, 
and they are thought to play impor-
tant roles in tumor progression (Afaq 
and Mukhtar, 2002). In response to the 
assault by ROS, cutaneous cells have 
developed several antioxidant defense 
systems, such as glutathione peroxidase, 
superoxide dismutase, and catalase, to 
protect against their detrimental effects.
Immunosuppression, attributed 
mainly to the UVB (290–320 nm) wave-
bands, is considered a prerequisite for 
skin cancer development in mice and 
humans.  UV irradiation suppresses 
immunity through multiple mecha-
nisms, including inhibition of antigen 
presentation, release of immunosup-
pressive cytokines, and the generation 
of regulatory lymphocytes (Afaq and 
Mukhtar, 2002). Gr-1+CD11b+ myeloid 
cells, which express surface markers 
common to both macrophage (Mac-1/
CD11b) and granulocyte (Gr-1) lineages 
and display features of undifferentiated 
myeloid cells, have been shown to accu-
mulate in the spleen and lymph nodes 
of tumor-bearing mice, where they 
inhibit antibody production, cytotoxic 
T-lymphocyte generation, and lympho-
cyte proliferative responses (Gabrilovich 
and Nagaraj, 2009). The accumulation of 
Gr-1+CD11b+ myeloid cells is often asso-
ciated with a large tumor burden, and 
surgical resection of such tumors is asso-
ciated with a decrease in the number of 
these cells in both human and mouse 
tumor models (Salvadori et al., 2000). 
The immature myeloid cells obtained 
from tumor-bearing mice possess sig-
nificantly higher levels of ROS than 
those isolated from tumor-free animals. 
Interestingly, hydrogen peroxide and not 
superoxide radical anions was found 
to be the major part of this increased 
ROS production, and catalase treat-
ment resulted in a greater than fourfold 
decrease in ROS levels in these animals 
(Kusmartsev and Gabrilovich, 2003).
Cellular antioxidants may therefore 
be considered molecules that, by aug-
menting the cellular defense systems, 
are ultimately responsible for cellular—
and probably organismic—longevity. 
Two studies, one in Drosophila and one 
in mice, have shown that overexpres-
sion of catalase in mitochondria results 
in a significant reduction in hydrogen 
peroxide generated by mitochondria 
and increased resistance to oxidative 
stress (Mockett et al., 2003; Schriner et 
al., 2005). Especially informative is the 
murine study (Schriner et al., 2005), in 
which an increase in expression of the 
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mitochondrial catalase gene was asso-
ciated with decreased oxidative stress 
resistance and increased life span.
The average life span of females is 
greater than that of males in several spe-
cies, including rats and humans (Vina et 
al., 2008). Different production of ROS 
may explain this difference in longev-
ity. Recent reports suggest that male 
rats not only produce more peroxides 
than females but also are less protected 
by a key cellular thiol, glutathione. 
In addition, oxidatively damaged 
mitochondrial DNA was found to be 
approximately fourfold higher in males 
than in females, and oxidation of mito-
chondrial DNA has been shown to be 
related to a decline of cellular function 
with age (Vina et al., 2006).
The presence of gender differences in 
the expression of antioxidant enzymes 
has been well documented. Studies in 
mice have shown profound differences 
in antioxidant responses with aging 
between sexes, with males displaying 
low levels of antioxidant enzymes such 
as superoxide dismutase, catalase, and 
glutathione reductase (Tomas-Zapico 
et al., 2006). The brains of female mice 
have reportedly lower oxidant and high-
er antioxidant capacity than those of 
males, mostly related to catalase activity 
(Sobocanec et al., 2003). Female rats dis-
play higher cytochrome c oxidase activ-
ity; consequently, mitochondria from 
female rats produce fewer ROS. In addi-
tion, they have an increased capacity to 
detoxify ROS due to higher superoxide 
dismutase and glutathione peroxidase 
activities (Vina et al., 2008).
There is considerable evidence that 
the higher levels of estrogen in females 
protect them against aging by interact-
ing with intracellular signaling path-
ways such as the mitogen-activated 
protein kinase, cyclic adenosine mono-
phosphate pathways, and the redox-
sensitive transcription factor nuclear 
factor-κB (Behl et al., 2000). Further 
proof that estrogen prevents oxidative 
stress has come from animal studies in 
which ovariectomy caused a signifi-
cant increase in mitochondrial perox-
ide production in rats. Moreover, when 
these ovariectomized rats were treated 
with estradiol, the rate of mitochondrial 
peroxide production decreased signifi-
cantly. It was further noted that the low 
concentrations of estrogens present in 
plasma did not act as chemical antioxi-
dants per se; however, they were able to 
activate a signal transduction program 
that resulted in the upregulation of anti-
oxidant genes (Vina et al., 2006).
Skin synthesizes locally significant 
amounts of sexual hormones with intra-
crine or paracrine actions. Emerging 
data support the concept that female sex 
hormones can also be protective in cuta-
neous carcinogenesis; in fact, Mancuso 
and colleagues (2009) recently reported 
that murine skin tumor development was 
significantly enhanced after ovarian hor-
mone withdrawal in two independent 
experimental models. Increased basal 
and squamous cell tumor incidence 
and multiplicity, and decreased tumor 
latency were observed in ovariectomized 
versus intact controls, showing that 
endogenous estrogens play a critical role 
in protection against carcinogenesis by 
several agents in mouse skin.
The results of Sullivan and col-
leagues’ study complement findings 
from several epidemiologic studies in 
humans as well as in animal experi-
mental models reporting gender dif-
ferences in skin cancer incidence. 
Dissecting the interplay between anti-
oxidants and hormone signaling will be 
critical to gaining a better mechanistic 
understanding of the impact of gender 
on disease pathogenesis. However, 
several questions remain unanswered. 
Does the reduced activity of antioxi-
dant enzymes, specifically catalases, in 
males represent direct steps in carcino-
genesis? Given the inverse correlation 
between Gr-1+CD11b+ cell percentages 
and catalase activity, what is the mecha-
nism by which these cells are regulated 
by the antioxidant enzyme system in 
response to UV irradiation? It will be 
interesting to explore the relative contri-
bution of estrogen to the sexual dimor-
phism observed in skin tumorigenesis 
and its relationship to the myeloid sup-
pressor cells.
Although they may not reflect the 
entire spectrum of cutaneous carcino-
genesis, the findings of Sullivan et al. 
(2012) extend our understanding of 
the underlying pathogenesis of the dis-
ease. Further work will be needed to 
determine whether catalase is useful 
in preventing or treating skin cancer. 
Chemical modification techniques have 
been used to control the tissue distribu-
tion of catalase, and the effectiveness 
of catalase delivery has been demon-
strated in animal models for hepatic 
ischemia/reperfusion injury, chemi-
cally induced tissue injuries, and tumor 
metastasis to the liver, lung, and peri-
toneal organs (Nishikawa et al., 2009). 
In this context, significant inhibition 
was observed in ROS-mediated oxida-
tive tissue damage and ROS-mediated 
upregulation of the expression of genes 
responsible for recruiting inflamma-
tory cells and for metastatic growth of 
tumor cells. Catalase can be used as a 
therapeutic agent, but its success will 
depend on entry of the enzyme into 
sites where ROS are generated. Because 
oxidative stress is implicated in several 
human diseases, catalase delivery could 
have wide application in the future. If 
substantiated in humans, this concept 
could aid in designing preventive mea-
sures and predicting the treatment out-
comes of patients with skin cancer.
Clinical Implications
•  Male mice are increasingly susceptible to skin carcinogenesis upon UVB 
radiation exposure as compared with their female counterparts; this 
finding is linked to decreased catalase activity in males versus females.
•  Catalase activity was inversely correlated with the expression of myeloid 
suppressor Gr-1+CD11b+ cells in the skin, emphasizing the specific 
regulatory role of this antioxidant on the immune system in response to 
UV irradiation.
•  If authenticated in humans, this approach may be a useful indicator 
of disease risk and aid in developing and evaluating strategies for 
countering carcinogenesis in susceptible populations.
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Realm of Revertant 
Mosaicism Expanding
Marcel F. Jonkman1 and Anna M.G. Pasmooij1
In this issue, Lai-Cheong et al. report a patient with Kindler syndrome who 
showed revertant mosaicism: a patch of normal-looking skin attributable to a 
reverse mutation. The molecular basis of the reverted patch appeared to be the 
deletion of a duplicated cytosine, thus restoring the reading frame of FERMT1 
transcripts. This finding further pushes the frontier of revertant mosaicism, a 
phenomenon of spontaneous gene repair, which can be seen with the naked 
eye in skin.
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Revertant mosaicism is universal
When Charles Darwin formulated his 
evolution theory in his 1859 book, 
On the Origin of Species by Means of 
Natural Selection, or, the Preservation 
of Favoured Races in the Struggle for 
Life, he may not have imagined that 
it also holds true for somatic cells 
within a single organism. If an organ-
ism is affected by a germline muta-
tion, spontaneous repair of the mutant 
gene in somatic cells that express the 
gene product may start a struggle of 
natural selection between revertant 
and mutant cells. When revertant cells 
expand because they have a growth 
advantage, revertant tissue develops, 
also called “natural gene therapy.”
At the “Natural Gene Therapy of the 
Skin” symposium held 7 November 
2011 in Barcelona as a satellite of the 
European Society for Dermatological 
Research meeting, Clifford Weil, plant 
biologist from Purdue University, 
Indiana, explained that in plants 
somatic mutation (variegation) and 
somatic reversion have been observed 
for thousands of years (Figure 1). It was 
in the 1950s that Barbara McClintock 
formulated the molecular theory 
of somatic reversion of “unstable 
mutations”: sections of chromosomes 
proposed to move into and out of 
genes. For her work on transposons she 
was awarded the Nobel Prize in 1983.
Revertant mosaicism was demonstrated 
in blood, muscle, liver, and skin
In humans, revertant mosaicism (RM) 
has been reported in genetic disor-
ders affecting self-regenerating organ 
systems, such as blood, muscle, liver, 
and skin (for reviews, see Jonkman, 
1999; Hirschhorn, 2003; Lai-Cheong 
et al., 2011). The genetic mechanisms 
underlying spontaneous gene repair in 
humans are mostly second-site muta-
tions (single-nucleotide transversions/
transitions and deletions) and homolo-
gous recombinations.
To observe RM in blood, muscle, or 
liver, a microscope and special stain-
ing are required, but in skin RM is vis-
ible to the naked eye. RM in skin was 
first reported by Jonkman et al. (1997) 
in the genetic disorder epidermoly-
sis bullosa (EB), which is character-
ized by lifelong fragile skin that easily 
forms blisters and erosions. Mutations 
in as many as 15 genes can result in 
EB. Four of these genes have shown 
to revert: KRT14 encoding keratin 14 
in EB simplex, LAMB3 encoding the 
β3 chain of laminin-332 (Pasmooij et 
